Invention Grant
- Patent Title: Peptides for the treatment of COVID-19
-
Application No.: US17699792Application Date: 2022-03-21
-
Publication No.: US11667678B2Publication Date: 2023-06-06
- Inventor: Kalipada Pahan
- Applicant: Rush University Medical Center
- Applicant Address: US IL Chicago
- Assignee: Rush University Medical Center
- Current Assignee: Rush University Medical Center
- Current Assignee Address: US IL Chicago
- Agency: Taft Stettinius & Hollister LLP
- Agent Joseph M. Bennett-Paris
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K38/16 ; A61P31/14
Abstract:
Compositions for inhibiting the binding between ACE2 and SARS-CoV-2 spike S1 are disclosed. Methods of treating COVID-19 are disclosed. Methods of making an in vivo model of COVID-19 are also disclosed.
Public/Granted literature
- US20220363722A1 Peptides for the Treatment of COVID-19 Public/Granted day:2022-11-17
Information query
